Novo Nordisk (NYSE:NVO) oral version of its blockbuster weight-loss drug Wegovy is emerging as the central battleground for ...

By Sneha S K May 8 (Reuters) - Eli Lilly's new weight-loss pill, Foundayo, was prescribed 7,335 times in the U.S. in the ...

Challenge for Danish group is to capitalise on first-mover advantage to beat Lilly on the US drugmaker’s home turf ...

Google today announced the Fitbit Air as a screen-less fitness tracker that has a low profile and affordable $99.99 price.

Eli Lilly's weight loss pill launch has been closely watched after the successful start of Novo Nordisk's Wegovy pill.

The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, including whether it could be linked to liver and heart problems, according to th ...

On May 4, 1996, Alanis Morisette began a historic run on the pop charts with her third studio album, Jagged Little Pill. The ...

Wegovy pill, the oral version of its blockbuster GLP-1 (glucagon-like peptide-1) weight-loss treatment, is tracking at ...

Novo Nordisk launched its Wegovy pill in January amid a battle in the weight loss drug market with Mounjaro manufacturer Eli ...

By HealthDay Staff HealthDay ReporterWEDNESDAY, April 15, 2026 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to ...

PARIS, France — After taking the pill for a decade, Elodie Monnier Legrand decided to try "natural" birth control, an ...

U.S. prescriptions for Eli Lilly’s (LLY) new obesity pill Foundayo reached 7,335 during the fourth week of its market launch, indicating a slight uptick compared to the prior week, according to ...